|Bid||0.0000 x 1000|
|Ask||0.0000 x 3200|
|Day's Range||3.0300 - 3.2900|
|52 Week Range||2.5550 - 7.7200|
|Beta (5Y Monthly)||-0.92|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 14, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Genprex will participate in conferences throughout May 2021.
Genprex expands its oncology franchise and intellectual property portfolio with a license amendment with a major cancer research center.
Our conferences are open to both institutional and retail investors, allowing all investors to obtain meaningful access to management teams" stated Hunter Diamond, CFA the CEO of Diamond Equity Research.Investors can register at https://www.